| Literature DB >> 35453223 |
Takashi Azuma1, Takashi Nakano2, Ryuji Koizumi3, Nobuaki Matsunaga3, Norio Ohmagari3,4, Tetsuya Hayashi1,5.
Abstract
The accuracy and correspondence between the measured concentrations from the survey and predicted concentrations on the basis of the three types of statistical antimicrobial use in Japan was evaluated. A monitoring survey of ten representative antimicrobials: ampicillin (APL), cefdinir (CDN), cefpodoxime proxetil (CPXP), ciprofloxacin (CFX), clarithromycin (CTM), doxycycline (DCL), levofloxacin (LFX), minocycline (MCL), tetracycline (TCL), and vancomycin (VMC), in the influent of sewage treatment plant (STP) located in urban areas of Japan, was conducted. Then, the measured values were verified in comparison with the predicted values estimated from the shipping volumes, sales volumes, and prescription volumes based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB). The results indicate that the correspondence ratios between the predicted concentrations calculated on the basis of shipping and NDB volumes and the measured concentrations (predicted concentration/measured concentration) generally agreed for the detected concentration of antimicrobials in the STP influent. The correspondence ratio on the basis of shipping volume was, for CFX, 0.1; CTM, 2.9; LFX, 0.5; MCL, 1.9; and VMC, 1.7, and on the basis of NDB volume the measured concentration was CFX, 0.1; CTM, 3.7; DCL, 0.4; LFX, 0.7; MCL, 1.9; TCL, 0.6; and VMC, 1.6. To our knowledge, this is the first report to evaluate the accuracy of predicted concentrations based on sales, shipping, NDB statistics and measured concentrations for antimicrobials in the STP influent.Entities:
Keywords: antimicrobials; national database of health insurance claims and specific health checkups of Japan (NDB); predicted environmental concentration; sewage influent; wastewater treatment plant (WWTP)
Year: 2022 PMID: 35453223 PMCID: PMC9027251 DOI: 10.3390/antibiotics11040472
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Properties of the target antimicrobials examined [46,47,48,49,50,51,52,53,54].
| Antimicrobials | Molecular Formula | Molecular Mass | Structure | Excretion Rate |
|---|---|---|---|---|
| Ampicillin | C16H19N3O4S | 349.4 |
| 71 [ |
| Cefdinir | C14H13N5O5S2 | 395.4 |
| 31 [ |
| Cefpodoxime proxetil | C21H27N5O9S2 | 557.6 |
| 50 [ |
| Ciprofloxacin | C17H18FN3O3 | 331.3 |
| 50 [ |
| Clarithromycin | C38H69NO13 | 748.0 |
| 24 [ |
| Doxycycline | C22H24N2O8 | 444.4 |
| 80 [ |
| Levofloxacin | C18H20FN3O4 | 361.4 |
| 83 [ |
| Minocycline | C23H27N3O7 | 457.5 |
| 36 [ |
| Tetracycline | C22H24N2O8 | 444.4 |
| 60 [ |
| Vancomycin | C66H75Cl2N9O24 | 1449.3 |
| 85 [ |
LC–MS/MS parameters and validations of each antimicrobial.
| Antimicrobials | Ionization | Precursor Ion | Product Ion | Cone Voltage | Collision Energy | Recovery | LOD | LOQ |
|---|---|---|---|---|---|---|---|---|
| Ampicillin (APL) | ESI+ | 350.2 | 29 | 24 | 75 (33) | 1.6 | 5.4 | |
| Cefdinir (CDN) | ESI+ | 369.2 | 170.0, | 30 | 20 | 72 (15) | 0.2 | 0.8 |
| Cefpodoxime proxetil (CPXP) | ESI+ | 557.5 | 30 | 18 | 89 (5) | 1.2 | 3.9 | |
| Ciprofloxacin (CFX) | ESI+ | 332.2 | 40 | 25 | 57 (3) | 0.7 | 2.2 | |
| Clarithromycin (CTM) | ESI+ | 748.2 | 316.6, | 38 | 18 | 74 (11) | 0.5 | 1.6 |
| Doxycycline (DCL) | ESI+ | 445.2 |
| 32 | 18 | 80 (9) | 0.3 | 1.0 |
| Levofloxacin (LFX) | ESI+ | 362.2 | 261.2, | 40 | 21 | 52 (6) | 0.3 | 1.0 |
| Minocycline (MCL) | ESI+ | 458.3 |
| 36 | 21 | 106 (18) | 0.3 | 1.0 |
| Tetracycline (TCL) | ESI+ | 445.2 | 28 | 20 | 70 (20) | 0.4 | 1.3 | |
| Vancomycin (VMC) | ESI+ | 724.2 | 82.9, | 17 | 18 | 110 (8) | 0.6 | 1.9 |
Product ions in italics were used for quantification.
Annual antimicrobial usage in the survey area [34,35,36].
| Antimicrobials | Antimicrobial Usage (Mean (SD)) | ||
|---|---|---|---|
| Sales * [ | Shipping * [ | NDB ** [ | |
| Ampicillin (APL) | 3313 (562) | N.A. | 182 (22) |
| Cefdinir (CDN) | 2810 (181) | 6707 (953) | 410 (101) |
| Cefpodoxime proxetil (CPXP) | 975 (276) | 1588 (588) | 130 (12) |
| Ciprofloxacin (CFX) | N.A. | 1405 (241) | 148 (13) |
| Clarithromycin (CTM) | 11,592 (3970) | 71,850 (15,086) | 5499 (63) |
| Doxycycline (DCL) | N.A. | N.A. | 93 (9) |
| Levofloxacin (LFX) | 1683 (536) | 32,548 (4441) | 2665 (11) |
| Minocycline (MCL) | N.A. | 4157 (905) | 377 (36) |
| Tetracycline (TCL) | N.A. | N.A. | 14 (6) |
| Vancomycin (VMC) | 158 (25) | 2905 (186) | 169 (7) |
*: Antimicrobial usage in Japan, **: Antimicrobial usage in the target area in this study, N.A.: Not available.
Figure 1Measured concentrations of targeted antimicrobials in STP influents (*: Not detected).
Predicted concentrations of antimicrobials in the target STP influent.
| Antimicrobials | Predicted Concentrations in the Targeted STP | ||
|---|---|---|---|
| Sales | Shipping | NDB | |
| Ampicillin (APL) | 99 (17) | N.A. | 78 (10) |
| Cefdinir (CDN) | 37 (2.4) | 87 (12) | 77 (19) |
| Cefpodoxime proxetil (CPXP) | 20 (5.8) | 33 (12) | 39 (3.4) |
| Ciprofloxacin (CFX) | N.A. | 29 (5.1) | 44 (4.2) |
| Clarithromycin (CTM) | 117 (40) | 724 (152) | 790 (0.1) |
| Doxycycline (DCL) | N.A. | N.A. | 48 (4.8) |
| Levofloxacin (LFX) | 59 (19) | 1134 (155) | 1335 (4.9) |
| Minocycline (MCL) | N.A. | 63 (14) | 82 (7.9) |
| Tetracycline (TCL) | N.A. | N.A. | 4.9 (1.8) |
| Vancomycin (VMC) | 5.6 (0.9) | 104 (6.6) | 87 (4.0) |
N.A.: Not available.
Figure 2Correspondence ratios for predicted/measured concentration of target antimicrobials in STP influents (*: Not detected).
Figure 3Relationship between correspondence ratios determined by using measured concentration values and the three types of predicted concentration values: (a) sales volume, (b) shipping volume, (c) NBD volume.